Relevance between MRI longitudinal relaxation rate and gadolinium concentration in Gd3+/GO/alginate nanocomposite

Document Type: Research Paper


1 Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

2 Department of Radiology, Tabriz University of Medical Sciences, Tabriz, Iran

3 Dental and Periodontal Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

4 Inorganic Chemistry Department, Faculty of Chemistry, University of Tabriz, Tabriz, Iran


Objective(s): Relevance between magnetic resonance imaging (MRI) relaxation rate and concentration of magnetic nanoparticles determines the capability of a nanomaterial to provide MRI contrast. In the present study, alginate was conjugated to gadolinium/graphene oxide nanocomposite to form gadolinium/graphene oxide/alginate nanocomposite, aiming to investigate its effect on the relevance between MRI longitudinal relaxation rate and paramagnetic gadolinium concentration.
Materials and Methods: The physicochemical properties of the nanocomposite and its effect on the cell culture were investigated. Moreover, MRI longitudinal relaxation rates were determined based on the corresponding exponential curves, and the graph of their relevance with gadolinium concentration was plotted.
Results: The average thickness and sheet size of the nanocomposite were three and 100 nanometers, respectively. The nanocomposite showed high cell viability, even at the relatively high concentration of 75 µg/ml. In addition, a linear correlation was observed between longitudinal relaxation rate and gadolinium concentration.
Conclusion: According to the results, the linearity between gadolinium/graphene oxide/alginate nanocomposite and gadolinium concentration, which revealed a high slope, confirmed the potential of the nanocomposite to significantly improve the positive contrast of MR images.


1.Li Y, Li CH, Talham DR. One-step synthesis of gradient gadolinium iron hexacyanoferrate nanoparticles: a new particle design easily combining MRI contrast and photothermal therapy. Nanoscale. 2015; 7(12): 5209-5216.
2.Babić-Stojić B, Jokanović V, Milivojević D, Požek M, Jagličić Z, Makovec D, Arsikin K, Paunović V. Gd2O3 nanoparticles stabilized by hydrothermally modified dextrose for positive contrast magnetic resonance imaging. J Magn Magn Mater. 2016; 403: 118-126.
3.Caravan P, Farrar CT, Frullano L, Uppal R. Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium‐and manganese‐based T1 contrast agents. Contrast Media Mol Imaging. 2009; 4(2): 89-100.
4.Engström M, Klasson A, Pedersen H, Vahlberg C, Käll PO, Uvdal K. High proton relaxivity for gadolinium oxide nanoparticles. Magn Reson Mater Phy. 2006; 19(4): 180-186.
5.Moasses Ghafary S, Hatamie S, Nikkhah M, Hosseinkhani S. The effect of graphite sources on preparation of photoluminescent graphene nano-sheets for biomedical imaging. Nanomed J. 2017; 4(3): 164-169.
6.Gollavelli G, Ling YC. Multi-functional graphene as an in vitro and in vivo imaging probe. Biomaterials. 2012; 33(8): 2532-2545.
7.Justin R, Tao K, Román S, Chen D, Xu Y, Geng X, Ross IM, Grant RT, Pearson A, Zhou G, MacNeil S. Photoluminescent and superparamagnetic reduced graphene oxide–iron oxide quantum dots for dual-modality imaging, drug delivery and photothermal therapy. Carbon. 2016; 97: 54-70.
8.Pardakhty A, Foroughi MM, Ranjbar M. Synthesis and characterization of CdO/GrO nanolayer for in vivo Imaging. Nanomed J. 2017; 4(3): 191-196.
9.Yang HW, Huang CY, Lin CW, Liu HL, Huang CW, Liao SS, Chen PY, Lu YJ, Wei KC, Ma CC. Gadolinium-functionalized nanographene oxide for combined drug and microRNA delivery and magnetic resonance imaging. Biomaterials. 2014; 35(24): 6534-6542.
10.Kanakia S, Toussaint JD, Chowdhury SM, Lalwani G, Tembulkar T, Button T, Shroyer KR, Moore W, Sitharaman B. Physicochemical characterization of a novel graphene-based magnetic resonance imaging contrast agent. Int J Nanomedicine. 2013; 8: 2821.
11.Ma X, Tao H, Yang K, Feng L, Cheng L, Shi X, Li Y, Guo L, Liu Z. A functionalized graphene oxide-iron oxide nanocomposite for magnetically targeted drug delivery, photothermal therapy, and magnetic resonance imaging. Nano Res. 2012; 5(3): 199-212.
12.Chen W, Yi P, Zhang Y, Zhang L, Deng Z, Zhang Z. Composites of aminodextran-coated Fe3O4 nanoparticles and graphene oxide for cellular magnetic resonance imaging. ACS Appl Mater Interfaces. 2011; 3(10): 4085-4091.
13.Zhang M, Cao Y, Chong Y, Ma Y, Zhang H, Deng Z, Hu C, Zhang Z. Graphene oxide based theranostic platform for T1-weighted magnetic resonance imaging and drug delivery. ACS Appl Mater Interfaces. 2013; 5(24): 13325-13332.
14.Zhang M, Liu X, Huang J, Wang L, Shen H, Luo Y, Li Z, Zhang H, Deng Z, Zhang Z. Ultrasmall graphene oxide based T1 MRI contrast agent for in vitro and in vivo labeling of human mesenchymal stem cells. Nanomedicine: NBM. 2018; 14(7): 2475-2483.
15.Faucher L, Tremblay M, Lagueux J, Gossuin Y, Fortin MA. Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI. ACS Appl Mater Interfaces. 2012; 4(9): 4506-4515.
16.Hifumi H, Yamaoka S, Tanimoto A, Akatsu T, Shindo Y, Honda A, Citterio D, Oka K, Kuribayashi S, Suzuki K. Dextran coated gadolinium phosphate nanoparticles for magnetic resonance tumor imaging. J Mater Chem. 2009; 19(35): 6393-6399.
17.Kumar S, Meena VK, Hazari PP, Sharma SK, Sharma RK. Rose Bengal attached and dextran coated gadolinium oxide nanoparticles for potential diagnostic imaging applications. Eur J Pharm Sci. 2018; 117: 362-370.
18.Korkusuz H, Ulbrich K, Welzel K, Koeberle V, Watcharin W, Bahr U, Chernikov V, Knobloch T, Petersen S, Huebner F, Ackermann H. Transferrin-coated gadolinium nanoparticles as MRI contrast agent. Mol Imaging Biol. 2013; 15(2): 148-154.
19.Tabesh H, Amoabediny GH, Nik NS, Heydari M, Yosefifard M, Siadat SR, Mottaghy K. The role of biodegradable engineered scaffolds seeded with Schwann cells for spinal cord regeneration. Neurochem int. 2009; 54(2): 73-83.
20.Douglas KL, Tabrizian M. Effect of experimental parameters on the formation of alginate–chitosan nanoparticles and evaluation of their potential application as DNA carrier. J Biomater Sci Polym Ed. 2005; 16(1): 43-56.
21.Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Prog Polym Sci. 2012; 37(1): 106-126.
22.Alam SN, Sharma N, Kumar L. Synthesis of graphene oxide (GO) by modified hummers method and its thermal reduction to obtain reduced graphene oxide (rGO). Graphene. 2017; 6: 1-18.
23.Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005; 40(11): 715-724.
24.Li Z,Ke H, Wang J, Miao Z, Yue X. Graphene oxide and gadolinium-chelate functionalized poly (lactic acid) nanocapsules encapsulating perfluorooctylbromide for ultrasound/magnetic resonance bimodal imaging guided photothermal ablation of cancer. J Nanosci Nanotechnol. 2016; 16(3): 2201-2209.
25.Zhang H, Wu H, Wang J, Yang Y, Wu D, Zhang Y, Zhang Y, Zhou Z, Yang S. Graphene oxide-BaGdF5 nanocomposites for multi-modal imaging and photothermal therapy. Biomaterials. 2015; 42: 66-77.
26.Yang HW, Huang CY, Lin CW, Liu HL, Huang CW, Liao SS, Chen PY, Lu YJ, Wei KC, Ma CC. Gadolinium-functionalized nanographene oxide for combined drug and microRNA delivery and magnetic resonance imaging. Biomaterials. 2014; 35(24): 6534-6542.